Name: Name:BMS 663068
Brand: AABLOCKS
SKU: AA00GTZ5
Rating: 90 (10 reviews)

Catalog No.: AA00GTZ5

864953-29-7 | BMS 663068

Pack Size： 1mg

Purity： 95%

1 week

$127.00 $89.00

Pack Size： 2mg

Purity： 95%

1 week

$180.00 $126.00

Pack Size： 5mg

Purity： 95%

1 week

$243.00 $170.00

Pack Size： 10mg

Purity： 95%

1 week

$316.00 $221.00

Pack Size： 25mg

Purity： 95%

1 week

$511.00 $358.00

Pack Size： 50mg

Purity： 95%

1 week

$734.00 $514.00

Pack Size： 100mg

Purity： 95%

1 week

$1,026.00 $718.00

Quantity

- +

Add to Card

Order Now

bulk Quotation Request

Technical Information

Catalog Number: AA00GTZ5

Chemical Name: BMS 663068

CAS Number: 864953-29-7

Molecular Formula: C25H26N7O8P

Molecular Weight: 583.4898

MDL Number: MFCD23098796

SMILES: COc1cnc(c2c1c(cn2COP(=O)(O)O)C(=O)C(=O)N1CCN(CC1)C(=O)c1ccccc1)n1cnc(n1)C

Properties

Complexity: 1020

Covalently-Bonded Unit Count: 1

Defined Atom Stereocenter Count: 0

Defined Bond Stereocenter Count: 0

Formal Charge: 0

Heavy Atom Count: 41

Hydrogen Bond Acceptor Count: 11

Hydrogen Bond Donor Count: 2

Isotope Atom Count: 0

Rotatable Bond Count: 8

Undefined Atom Stereocenter Count: 0

Undefined Bond Stereocenter Count: 0

XLogP3: -0.1

Downstream Synthesis Route

864953-29-7

77-86-1

864953-39-9

[1]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-US2005/209246,2005,A1Locationinpatent:Page/Pagecolumn46-48;54

864953-29-7

CASUnavailable

[1]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-US2005/209246,2005,A1Locationinpatent:Page/Pagecolumn36;37

864953-38-8

864953-29-7

[1]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-US2005/209246,2005,A1Locationinpatent:Page/Pagecolumn46;48;54;55

[2]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-US2005/209246,2005,A1Locationinpatent:Page/Pagecolumn35;36;37;39

864953-29-7

77-86-1

864953-39-9

[1]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-US2007/155702,2007,A1Locationinpatent:Page/Pagecolumn12

864953-29-7

942117-71-7

[1]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-US2007/155702,2007,A1Locationinpatent:Page/Pagecolumn12

Literature fold

Title: Pharmacodynamics, safety, and pharmacokinetics of BMS-663068, an oral HIV-1 attachment inhibitor in HIV-1-infected subjects.

Journal: The Journal of infectious diseases20121001

Title: Nowicka-Sans B, et al. In vitro antiviral characteristics of HIV-1 attachment inhibitor BMS-626529, the active component of the prodrug BMS-663068. Antimicrob Agents Chemother. 2012 Jul;56(7):3498-507.

Building Blocks More >

891494-64-7

(S)-6-Bromo-3-(1-methyl-1h-pyrazol-4-yl)-5-(piperidin-3-yl)pyrazolo[1,5-a]pyrimidin-7-amine

AA00GU3O | MFCD23135226

90389-71-2

N-(3-Nitrobenzyl)ethanamine hydrochloride

AA00GU86 | MFCD07110182

875159-65-2

(2E)-3-[5-(2-METHYLCYCLOPROPYL)-2-FURYL]ACRYLIC ACID

AA00GUB7 | MFCD07838448

936630-57-8

(R)-3-Amino-4-(2,4,5-trifluorophenyl)butyric acid

AA00GUFN | MFCD07363507

878465-67-9

4-(Chloromethyl)-N-(4-methoxyphenyl)benzamide

AA00GUPX | MFCD08245261

914349-67-0

4-(4-Ethylpiperazin-1-ylmethyl)benzylamine

AA00GUZ1 | MFCD06797801

92259-86-4

Indolin-1-amine, HCl

AA00GVBD | MFCD04037889

915922-13-3

N-[(1-methyl-1H-imidazol-2-yl)methyl]propan-1-amine

AA00GVG4 | MFCD08691582

915707-61-8

3-[(6-Methylpyrazin-2-yl)oxy]aniline

AA00GVKJ | MFCD09702406

877802-01-2

2-[(4-Chloro-1,2,5-thiadiazol-3-yl)(methyl)amino]ethanol

AA00GVP9 | MFCD05668093